Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06199518 |
Other study ID # |
34619/4/21 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
April 1, 2021 |
Est. completion date |
April 1, 2023 |
Study information
Verified date |
December 2023 |
Source |
Tanta University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
a prospective comparative study designed to compare the outcomes of transperitoneal
Laparoscopic ureterolithotomy (T-LUL), mini-percutaneous antegrade ureteroscopy (A-URS) and
retrograde ureteroscopy (R-URS) in treating patients with LPUS (15-20 mm). the following
parameters were assessed and compared (demographic data and stones characteristics, Stone
free rate and complications)
Description:
we aimed in the current study to comprehensively evaluate and to compare the outcome of
transperitoneal laparoscopic ureterolithtomy, retrograde ureteroscopy and mini-percutaneous
antegrade ureteroscopy for management of large proximal ureteric stone (15 -20 mm) with
regards to; operative time, stone free rate, success rate, hospital stay and complications.
A total of 105 participants were enrolled in the trial between April 2021 and June 2023 to
accomplish this. Inclusion criteria for this study included patients who had a single
proximal Ureteral stone (between the pelvi ureteric junction and the upper border of the
sacroiliac joint) measuring 15-20 mm in diameter.
Patients were randomly allocated to receive either TPLU, RURS, or Minin-perc Antegrade URS,
with a 1:1:1 allocation ratio. After providing informed permission, the patients were
randomly assigned to one of three groups: Group I (35 patients treated with TPLU), Group II
(35 patients treated with RURS), and Group III (35 patients not treated with either TPLU or
RURS) (Included 35 patients who were treated by Mini-perc Antegrade URS)